Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-07-14 00:00:00 ET · period of report 2021-07-12 · accession 0001209191-21-046677 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-14 | 2021-07-12 | TXG | CRUTCHFIELD BRADFORD | Chief Commercial Off | S - Sale+OE | $186.53 | -17.0K | 44.5K | -28% | -$3.17M |
| D | 2021-07-14 | 2021-07-12 | TXG | CRUTCHFIELD BRADFORD | Chief Commercial Off | M - OptEx | $1.16 | +17.0K | 60.6K | +39% | +$19.7K |
| D | 2021-07-14 | 2021-07-12 | TXG | CRUTCHFIELD BRADFORD | Chief Commercial Off | M - OptEx | $0.00 | -17.0K | 511.0K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-07-12 | S | D | 4,400 | $185.87 | 50,451 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $185.47 to $186.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-07-12 | S | D | 3,933 | $187.31 | 46,518 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $186.90 to $187.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2021-07-12 | S | D | 1,512 | $188.32 | 45,006 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $188.015 to $188.945. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-07-12 | S | D | 5,755 | $185.07 | 54,851 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $184.47 to $185.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2021-07-12 | S | D | 600 | $190.86 | 43,906 | D | — | — | (F8) This transaction was executed in multiple trades at prices ranging from $190.41 to $191.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Common | Class A Common Stock | 2021-07-12 | S | D | 300 | $191.60 | 43,606 | D | — | — | (F9) This transaction was executed in multiple trades at prices ranging from $191.445 to $191.91. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 7 | Common | Class A Common Stock | 2021-07-12 | M | A | 17,000 | $1.16 | 60,606 | D | — | — | (F2) Includes an aggregate of 344 shares previously acquired under the Issuer's 2019 Employee Stock Purchase Plan. |
| 8 | Common | Class A Common Stock | 2021-07-12 | S | D | 500 | $189.36 | 44,506 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $189.07 to $189.75. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 9 | Derivative | Stock Option (right to buy) | 2021-07-12 | M | D | 17,000 | $0.00 | 511,000 | D | $1.16 · — to 2027-02-03 | 17,000 Class A Common Stock | (F10) This option, originally for 800,000 shares, of which 289,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |